In conclusion, we confirm the efficacy of hydroxychloroquine associated with azithromycin
in the treatment of COVID-19 and its potential effectiveness in the early impairment of
contagiousness.
mediterranee-infection.com/wp-content/upl…
in the treatment of COVID-19 and its potential effectiveness in the early impairment of
contagiousness.
mediterranee-infection.com/wp-content/upl…
"In 80 in-patients receiving a combination of hydroxychloroquine and azithromycin
we noted a clinical improvement in all but one 86 year-old patient who died, and one 74 year old patient still in intensive care unit."
we noted a clinical improvement in all but one 86 year-old patient who died, and one 74 year old patient still in intensive care unit."
"A rapid fall of nasopharyngeal viral load tested by
qPCR was noted, with 83% negative at Day7, and 93% at Day8. Virus cultures from patient
respiratory samples were negative in 97.5% patients at Day5."
qPCR was noted, with 83% negative at Day7, and 93% at Day8. Virus cultures from patient
respiratory samples were negative in 97.5% patients at Day5."
"This allowed patients to rapidly
de discharge from highly contagious wards with a mean length of stay of five days. We
believe other teams should urgently evaluate this cost-effective therapeutic strategy, to both
avoid the spread of the disease and treat patients as soon
de discharge from highly contagious wards with a mean length of stay of five days. We
believe other teams should urgently evaluate this cost-effective therapeutic strategy, to both
avoid the spread of the disease and treat patients as soon
as possible before severe respiratory
irreversible complications take hold. "
irreversible complications take hold. "
"By administering hydroxychloroquine combined with
azithromycin, we were able to observe an improvement in all cases, except in one patient who
arrived with an advanced form, who was over the age of86, and in whom the evolution was
irreversible."
azithromycin, we were able to observe an improvement in all cases, except in one patient who
arrived with an advanced form, who was over the age of86, and in whom the evolution was
irreversible."
"a combination
of 200 mg of oral hydroxychloroquine sulfate, three times per day for ten days combined with
azithromycin (500mg on D1 followed by 250mg per day for the next four days). "
of 200 mg of oral hydroxychloroquine sulfate, three times per day for ten days combined with
azithromycin (500mg on D1 followed by 250mg per day for the next four days). "
"For patients
with pneumonia and NEWS score≥5, a broad spectrum antibiotic (ceftriaxone) was added to
hydroxychloroquine and azithromycin. "
with pneumonia and NEWS score≥5, a broad spectrum antibiotic (ceftriaxone) was added to
hydroxychloroquine and azithromycin. "
